Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Clinical trial NCT01508702 · COMPLETED
Trial details
- NCT number
- NCT01508702
- Sponsor
- Ardea Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-10-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.